Medindia

X

pharmasol Announces Strategic psiXchange Deployment with Leading CRO

Wednesday, November 16, 2016 Medical Gadgets J E 4
Advertisement

KAISERSLAUTERN, Germany, November 16, 2016 /PRNewswire/ --

pharmasol, a global leader in software development and product implementation for the life sciences industry, today announced a new strategic customer for its flagship product, psiXchange.

psiXchange supports the automation, control and management of any complex business process, enabling pharmaceutical, medical device companies and CROs to distribute safety documents to investigators, ethics committees, study-team members and anyone else working on a clinical trial. psiXchange is the only system available which can fully automate this business process; without changing existing delivery methods or making recipients learn a new system.

The global maintenance of country reporting requirements eliminates the need to configure the system for every new trial and the automatic escalation of distribution channel, for instance from e-mail to fax to courier avoids the need for manual intervention.

This new customer, one of the top 10 CROs, will integrate psiXchange with existing applications and processes to allow for the delivery of safety documents with complete tracking and full audit of all activities.

Suitable for CROs and sponsors alike, psiXchange can be used for other document distribution tasks, for example investigator brochures or protocols.

About pharmasol

pharmasol is a leading provider of innovative applications, GxP compliant hosting and implementation services to the life sciences industry. With tools to automate complex business processes and the option to host applications in a secure managed data centre, pharmasol is trusted by leading pharmaceutical, medical device and contract research companies to optimize workflows and ensure compliance. 

http://www.psixchange.com

Contact: Tim Billington +44-7768-336-302 Tim.billington@pharmasol.de

SOURCE pharmasol

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Marapharm Ventures Inc. Announces an Agreement to ...
S
#RememberRoadVictims: November 16, 2016 - National...